Agilent Technologies Inc.
Agilent Technologies Reorganizes Operational Structure
Summary
Agilent Technologies, Inc. announced a reorganization of its operational structure into three new reportable segments: life sciences and diagnostics markets, applied markets, and Agilent CrossLab. This restructuring will be reflected in the company's financial statements starting from the quarter ending January 31, 2025, with prior periods recast accordingly. The unaudited segment information for the past fiscal years and quarters is provided as an exhibit to this report.
Profitelligence Alerts
Get alerts for A
Be first to know when Agilent Technologies Inc. files with the SEC.
Filing Categories
Exhibits (1)
Advertisement
About Agilent Technologies Inc.
Agilent Technologies Inc. is a global leader in the development and provision of life sciences, diagnostics, and applied chemical markets. Primarily focused on delivering superior analytical instruments, software, services, consumables, and reagents, the company plays a critical role in supporting the research needs of pharmaceutical, biotechnology, and government laboratories. Agilent's robust portfolio includes innovative solutions for genomics, proteomics, and metabolomics, aiding in critical areas such as disease research, food safety, and environmental analysis. Established in 1999 as a spin-off from Hewlett-Packard, the company leverages its heritage of technological innovation to enhance analytical capabilities for its clients. Agilent's significant contributions to health and safety applications underscore its importance in advancing scientific understanding and supporting public health initiatives worldwide.
Official SEC Documents
Advertisement